BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16460871)

  • 1. Recurrent endometrial cancer: a retrospective study.
    van Wijk FH; Huikeshoven FJ; Abdulkadir L; Ewing PC; Burger CW
    Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):114-20. PubMed ID: 16460871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pulmonary recurrences in patients with endometrial cancer.
    Dowdy SC; Mariani A; Bakkum JN; Cliby WA; Keeney GL; Podratz KC
    Gynecol Oncol; 2007 Nov; 107(2):242-7. PubMed ID: 17869330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients.
    Sartori E; Pasinetti B; Carrara L; Gambino A; Odicino F; Pecorelli S
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S241-7. PubMed ID: 17826824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse and survival in early-stage ovarian cancer.
    Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
    Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme.
    Reddoch JM; Burke TW; Morris M; Tornos C; Levenback C; Gershenson DM
    Gynecol Oncol; 1995 Nov; 59(2):221-5. PubMed ID: 7590477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage cytoreductive surgery for recurrent endometrial cancer.
    Bristow RE; Santillan A; Zahurak ML; Gardner GJ; Giuntoli RL; Armstrong DK
    Gynecol Oncol; 2006 Oct; 103(1):281-7. PubMed ID: 16631236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment and prognosis of low-grade malignant endometrial stromal sarcoma].
    Ma SK; Zhang HT; Wu LY; Liu LY; Li B
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):74-8. PubMed ID: 17575701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoluminal resection for sessile neoplasia in the GI tract is associated with a low recurrence rate and a high 5-year survival rate.
    Wang AY; Ahmad NA; Zaidman JS; Brensinger CM; Lewis JD; Long WB; Kochman ML; Ginsberg GG
    Gastrointest Endosc; 2008 Jul; 68(1):160-9. PubMed ID: 18577483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
    Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
    Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis.
    Zola P; Fuso L; Mazzola S; Piovano E; Perotto S; Gadducci A; Galletto L; Landoni F; Maggino T; Raspagliesi F; Sartori E; Scambia G
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S150-4. PubMed ID: 17868785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma.
    Rose PG; Sommers RM; Reale FR; Hunter RE; Fournier L; Nelson BE
    Obstet Gynecol; 1994 Jul; 84(1):12-6. PubMed ID: 8008305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic features of bone metastases and outcomes in patients with primary endometrial cancer.
    Kehoe SM; Zivanovic O; Ferguson SE; Barakat RR; Soslow RA
    Gynecol Oncol; 2010 May; 117(2):229-33. PubMed ID: 20199802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
    Hoekstra AV; Kim RJ; Small W; Rademaker AW; Helenowski IB; Singh DK; Schink JC; Lurain JR
    Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the sentinel node procedure to stage endometrial cancer.
    Ballester M; Dubernard G; Rouzier R; Barranger E; Darai E
    Ann Surg Oncol; 2008 May; 15(5):1523-9. PubMed ID: 18322758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of routine follow-up in patients treated for carcinoma of the vulva.
    Oonk MH; de Hullu JA; Hollema H; Mourits MJ; Pras E; Wymenga AN; van der Zee AG
    Cancer; 2003 Dec; 98(12):2624-9. PubMed ID: 14669281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical resection of recurrent endometrial carcinoma.
    Awtrey CS; Cadungog MG; Leitao MM; Alektiar KM; Aghajanian C; Hummer AJ; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Sep; 102(3):480-8. PubMed ID: 16490236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs and benefits of routine follow-up after curative treatment for endometrial cancer.
    Agboola OO; Grunfeld E; Coyle D; Perry GA
    CMAJ; 1997 Oct; 157(7):879-86. PubMed ID: 9327795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.